Ladies and gentlemen, welcome to the update for the 3 months ended March 31, 2019 Conference Call. I'm Sherry, the Chorus Call operator. I would like to remind you that all participants will be in listen only mode and the conference is being recorded. The presentation will be followed by The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Mr.
Richard Burden, Head of Investor Relations and Rating Agency Management. Please go ahead, sir.
Good morning, good afternoon, everybody, and welcome to Zurich Insurance Group's Q1 2019 Q and A Call. On the call today is our group CFO, George Quinn. Before we start with the Q and A, I'd just like to remind you, please keep your questions to a maximum of 2, and if we have time, we'll come back to you later on in the call. But before we start with the Q and A, George will just make a few introductory remarks. George, over to you.
Thanks, Richard, and good morning and good afternoon to all of you. Thanks for joining the Q1 call. Just a reminder before we start the Q and A, the focus obviously on Q1 and again at Q3 this year is on revenue trends and also some qualitative commentary on the performance of the business. You'll see the full earnings detail again at the half year. Over the Q1, we have made a strong start to the year, and we believe that we're fully on track to meet or exceed all of the targets for this year.
The results clearly show that the strategy is working. And while the quarter has also seen benefits from the full inclusion of the Latin American acquisitions that we announced last year, we've also continued to strengthen our customer and partnership propositions with the group having entered into a number of incremental distribution agreements in the year to date. Perhaps most notably, P and C pricing trends have continued to improve, particularly in North America, and if anything, have accelerated over the course of the quarter. Rate is clearly in excess of claims cost. And the rest of the world trends have remained broadly stable, And we have seen some strong performances, particularly in our Swiss business as well as from some of our smaller country units.
In terms of nat cat and weather, I would describe the Q1 as relatively benign. There have been a number of weather events around the world. These have tended to focus on areas where we are less exposed than perhaps some of our peers are, resulting in overall cat losses that are slightly below our normal quarterly expectations. Our Life business also continued to deliver on the strategy of focusing on Capital Life and Protection Business. And this continues to support good growth, which aims to balance return on capital, cash generation and new business margins, which, as you've seen today, remain at an attractive level.
Our Swiss and Irish businesses have had a particularly strong performance over the quarter in the Corporate Life and Pensions segment. Pharma's continued to deliver steady performance, continue to execute on its strategy to strengthen the agency force and customer metrics have continued to improve. The surplus ratio has improved further and stands at the highest level for the exchange for some time. And of course, this will support future growth in the business. The quarter also confirms our very strong capital position with our Z ECM ratio at 125%, providing us with continued capital flexibility.
We continue to review opportunities to release from non core areas of the business. And following the announced sale of the UK Employers' Liability book back in December and the more recent announcement of the transfer of a U. S. A and E book to NSTAR in April, we've effectively removed all legacy A and E exposure A and
The first question comes from the line of Michael Huttner, JPMorgan. Please go ahead.
Good morning. Good afternoon. Great results. And on the pricing or for them, I'm not sure which, the our delays, plus 4% like for like growth in terms of volume pricing, plus 2%. Is the volume or the premium total of 4%, given that you've kind of got half made us understand it'd be flat this year?
A clear decision by the group saying that, yes, at cost margins, yes, we'll open the tap. And in other words, will reach better than 96% by the end of the year. And then the second question on solvency, You did say it was strong. I was hoping that you would kind of say, oh yes, but we had to adjust full year and there's the reason why. I just wondered whether you could explain a little bit the moving parts.
The 125,000,000 which for me is the same figure as December, obviously, for you, it's up 1%. It doesn't feel as strong as I was hoping. And this one is something missing. I would have expected the sale of these back books to release more capital.
Thanks, Michael. So on the first question on pricing, I guess, we don't open the tab kind of people, are we? Again, we typically have a far more disciplined approach than that. I think if you look at what drives it, I referred to some of it in the intro. I mean, in some markets, I mean, we have seen stronger growth than we expected.
And some of that was, I mean, part of the direction we gave the business. Some of it is tactical just given market conditions. But we certainly haven't sent a message to the business that now is the time to go all in across the market. And in fact, I mean, last night, we briefed our leadership team call, our leadership team on the information we were presenting today. And one of our most senior underwriters joined the call to say that it's important that all the underwriters focus on the trade off between retention and price.
Just given the current market conditions, you can probably push a bit harder. So there isn't a volume goal out there. We haven't instructed people to grow across the various markets. But in some places, over the course of Q1, we've not able to achieve the rates, which I'll come to in a second. But some of our businesses, for example, the Swiss one, have produced good growth.
On the rates topics, if you allow me, I'll make a couple of comments on that before I move to the solvency topic. I think if I mean, certainly, if you listen to us after the year end on the roadshow, I'd say that we had a pretty cautious outlook on pricing. So I mean, if you now look at what we've seen in the Q1, especially in the U. S, I mean, the headline rate is now higher in Q1 than it was in any quarter last year. We're a bit over 4%.
And we see the claims inflation trends to be broadly consistent with the figures that we saw last year. So just in the low 2s. So if this continues, I mean, there is the potential of reasonable margin expansion. For the benefit of those of you that may try and compare the pricing numbers that we have to the ones you got from the peer group over the course of the last few days. I mean, the ex workers' comp number would be about plus 6, just to put it in context.
On the solvency topic, I think you're completely right. I think the reason that you don't quite see the picture that you might have expected, I mean, given the market movements from a spread and an equity perspective, certainly, we expect to see some recovery of the change we saw in Q4. I mean, what really offsets this is mainly interest rates actually. So a combination of interest rates, and in particular, the shape of the curve is what drives this currently, particularly impacting the pension fund side of things. So yes, I take the point.
I guess my intro comment was more about the absolute level than the relative positioning.
Okay.
Next question comes from the line of Andrew Ritchie, Autonomous. Please go ahead.
Hi, there. I guess one of the reasons why pricing appears to have picked up is there's greater fear on the industry on the state of, let's call it, prior loss costs, not current loss cost trends, particularly in casualty lines. I mean, can you give us any sense of have you looked again recently at what's in terms of developing in terms of underlying loss trends on your liability reserves in particular? Have you felt the need to take any more remedial action? You've been adding you've been taking some of the good news in workers' comp and adding to those lines.
I guess I'm just trying to get some sense about the real confidence in higher prices coming through to better margin or whether they may get even up in more conservative loss picks given the heightened uncertainty on prior year loss trends for the industry? And secondly, could you give us a quick update in Australian Life or the 1 part deal closure? Industry trends appears they've got worse again in terms of claims. And is that going to affect the likely profit coming from that acquisition? Thanks.
Thanks, Andrew. So on the drivers behind the pricing change, I mean, my gut feel is it's more than just a fear about prior development or even the need to have a more conservative pick on the current accident year. I mean, that may be an element of it. But there's a basic profitability challenge, and you see it in the commercial market more broadly last year. For us, I mean, as you guys all know, I mean, even though we don't publish the detailed results today, we run Q1 in the same way that we run any other quarter.
We've been through our normal reserve process. I mean, there's nothing in that that had I presented it today would have surprised you. You referred to the fact that last year, we had made some changes, especially in the U. S, where we've seen pretty strong growth reserve release around the workers' comp topic, and we've recycled some of that into more conservative positions on, for example, GL. That's not something that's continued into Q1.
I mean, we I mean, like any business, we have pockets of reserves that are more challenging. We have other pockets that are certainly more positive. And we still see the bias as more positive than negative in our book. And maybe just to set some of the current accident year side of things. Again, I think there I mean, given the action that we've taken last year, we would expect to see improvements in current accident year picks, especially around the U.
S. And again, from a as I look out towards the end of this half, from a formal report, I'm not seeing any evidence that would lead me to expect to see something other than that at this stage. Australian Life, so I mean, I guess you guys you've heard from the reinsurers over the last few days, and you've seen already some of the challenges in the market because of the Royal Commission topics. Maybe I'll talk on industry, then I'll talk about our own business and how that performs, and I'll touch on closure date. So in industry, more broadly, you've seen a number of challenges both on growth and on DI in Australia, particularly impacts the bank owned sector.
So certainly impacts the business that we intend to acquire. From a Zurich perspective, I mean, our business actually has been doing very well. So we've taken market share over this period. The business has suffered a bit on DI, but the overall performance continues to be pretty strong. And in fact, the I mean, the Australia recently gave us an update.
And if we had been presenting the Investor Day presentation today, you would see stronger numbers in terms of the outcome for Australia Life. So I think there will be more work to do around OnePath when we acquire it. That's not entirely a surprise given what we knew was coming. But the Banco and sector certainly has more challenges than maybe the other names, including Zurich, have currently. In terms of closure, we expect it to close in Q2.
So we should own this by the end of the quarter. Thank you.
Next question comes from the line of Nick Holmes, Societe Generale. Please go ahead.
Hi there. Thank you very much. Just one question, following up really on the question that's been asked before, but in a different way. Do you still expect the combined ratio to be at the upper end of the 95% to 96% target range? Or could it be better?
I mean, that's basically what the numbers are suggesting. Or is it just too early to say? Thank you.
Thanks, Nick. That's a very good way of asking the same question. The so I mean, we're not changing the guidance around the combined ratio today. So we've told you to expect that we'll see this at the upper end of the range. I mean, we are seeing more positive signals than we expected around pricing, but we're not currently changing guidance.
Okay. So it's too early to say?
That's what that would imply.
Yes. Lovely. Thank you very much.
The next question comes from the line of Vinit Malhotra, Mediobanca. Please go ahead.
Hi, everybody. Just quickly, maybe one question because my pricing question has been addressed. The growth that we saw in EMEA, particularly Switzerland, you say Swiss commercial. Is it the commercial like large commercial? Is it retail?
Is it international programs? Or is it domestic? Are you able to give us a bit of color? The reason for asking this is also, again, a bit of follow-up on an earlier question from Michael that how is the growth how are you thinking about your portfolio and the growth? So basically, what has happened in Switzerland commercial space?
Thank you.
Yes. So today, our Swiss business is it has been focused on the larger end of Commercial. And in fact, one of the things that the team has been doing is trying to find ways to be a more significant player on SME. But certainly, the growth that you see in Q1 is driven by traditional markets and Swiss Commercial.
I think we're hopeful that over the course
of this year, certainly next year, that we'll see the business here take up a more significant market position around SME. But that's not what's driving it in Q1.
And this was a higher combined ratio in the past, the large commercial hospital. Is that one of the reasons why you're
no? No, no. Sorry to interrupt you, Vinny. So I mean, I think you have to have it in your mind that when you look at large commercial generally in the global business, I mean, you tend to associate it with higher combined ratios, that's just not true of the Swiss business. Swiss business is very attractive.
So I mean, we're delighted to see this growth here.
Okay. Thank you very much.
That was the last question.
Thank you very much, everybody, for dialing in today. Obviously, if you do have further questions, please don't hesitate to call any of the Investor Relations team. And with that, thank you very much, and have a good afternoon.
Ladies and gentlemen, the conference is now over. Thank you for choosing Chorus Call and thank you for participating in the conference. You may now disconnect your lines.